SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001079973-23-000666 from Nemaura Medical Inc. (NMRD) (CIK 0001602078)

Nemaura Medical Inc. (NMRD) (CIK 0001602078)
Date: May 11, 2023 · CIK: 0001602078 · Accession: 0001079973-23-000666

AI Filing Summary & Sentiment

File numbers found in text: 333-270511

Date
May 11, 2023
Author
/s/ Dewan F.H. Chowdhury
Form
CORRESP
Company
Nemaura Medical Inc. (NMRD) (CIK 0001602078)

Letter

Office of Industrial Applications and Services Washington, D.C. 20549 Re: Nemaura Medical, Inc. Registration Statement Filed on Form S-1 File No. 333-270511

Dear Ms. Adams:

On behalf of Nemaura Medical, Inc. (the “Company”), in accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective at 4:00 P.M. Eastern Time on Friday, May 12, 2023, or as soon thereafter as is practicable.

The Company acknowledges that:

● should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

● the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

● the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

Sincerely,
/s/ Dewan F.H. Chowdhury

Show Raw Text
CORRESP
1
filename1.htm

Correspondence

NEMAURA MEDICAL, INC.

57 West 57th Street

New York, New York 10019

May 11, 2023

CORRESPONDENCE FILING VIA EDGAR

Ms. Abby Adams

Office of Industrial Applications and Services

U.S. Securities and Exchange Commission

100 F Street, N.E.

Washington, D.C. 20549

    Re:
    Nemaura Medical, Inc.

    Registration Statement Filed on Form S-1

    File No. 333-270511

Dear Ms. Adams:

On behalf of Nemaura Medical,
Inc. (the “Company”), in accordance with Rule 461 under the Securities Act of 1933, as amended, the undersigned respectfully
requests that the effective date for the Registration Statement referred to above be accelerated so that it will be declared effective
at 4:00 P.M. Eastern Time on Friday, May 12, 2023, or as soon thereafter as is practicable.

The Company acknowledges that:

    ●
    should the Commission or the staff, acting pursuant to delegated authority, declare the filing effective, it does not foreclose the Commission from taking any action with respect to the filing;

    ●
    the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the filing effective, does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the filing; and

    ●
    the Company may not assert staff comments and the declaration of effectiveness as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

    Sincerely,

    /s/ Dewan F.H. Chowdhury

    Dewan F.H. Chowdhury

    Chief Executive Officer

    cc:
    Craig D. Linder, Esq./Anthony L.G., PLLC